ChanTest to Debut Ion Channel Cell Line Business Next Month | GenomeWeb
ChanTest will launch a new ion channel cell line supply business next month in Boston at IBC’s Drug Discovery and Development of Innovative Therapeutics World Congress, a company official told CBA News this week.
“We have not been selling our cell lines to customers until this point because we have not fully validated and optimized them on the different platforms,” ChanTest CEO Arthur Brown said. “Now we have.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.